Target intelligence / Profile preview

DDN and PRKAG1 antisense RNA 1 (DDN-AS1)

Target: DDN-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

DDN and PRKAG1 antisense RNA 1 (DDN-AS1) is a long non-coding RNA (lncRNA) transcribed in antisense orientation relative to the DDN and PRKAG1 genes. It is categorized as an antisense RNA and has been identified as overexpressed in certain cancers, including cervical cancer, where its expression is associated with a poor prognosis[5][6]. As an lncRNA, DDN-AS1 may act through a variety of mechanisms typical for antisense RNAs, such as regulation of the expression of neighboring or overlapping genes and modulation of chromatin structure or transcriptional programs[3][4]. There is limited evidence directly linking DDN-AS1 to therapeutic drug interactions or use as a drug target, biomarker, or direct mechanism of cancer treatment. The principal role identified is in the regulation of gene expression and cancer progression.

Other names: CAT1507

Biological functions

Regulation of gene expression (at transcriptional and/or post-transcriptional level)Acts as a molecular scaffold, protein decoy, and mediator of RNA-protein complexes (inferred from general function of antisense and lncRNAs[3][4])

Disease associations

Cancer (overexpressed in certain cancers, such as cervical cancer, and associated with poor prognosis[5][6])Other (potential regulatory roles inferred from general asRNA functions)

Beyond the preview

Go deeper on DDN and PRKAG1 antisense RNA 1 (DDN-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DDN and PRKAG1 antisense RNA 1 (DDN-AS1).

Explore the full profile